Document Detail
Research Title: DRCR Protocol H Bevacizumab (Avastin) vs. Laser for Diabetic Macular Edema
Sponsor: National Eye Institute
Investigators: John S. Pollack, M.D., Principal Investigator; Joseph M. Civantos, M.D.
Description: To determine whether Bevacizumab (Avastin) at doses of 1.25mg, 2.5mg alone or in combination with PDT produce a greater benefit for Diabetic Macular Edema
Start Date: 06/01/06
Recruitment: Closed to Follow Up
Project Personnel: Barb C.
Location(s): Illinois Retina Associates, S.C., 300 Barney Drive #D, Joliet, IL 60435
|